World Clonorchiasis Market Analysis Latest Report by Major Growth Drivers – Pfizer, Bayer AG, Provet , Virbac , Cipla , Novartis AG, CIRON Drugs & Pharmaceuticals Pvt. Ltd., Merck & Co., Inc. Outlook 2023

Market Research Future has declared the expansion of the "Worldwide Clonorchiasis Market Research Report which gives Market Size, Shares and Forecasts till 2023.

Global Clonorchiasis Market -Highlights

Clonorchiasis is an infectious disease caused by the Chinese liver fluke Clonorchis sinensis. Clonorchiasis is dominant in Asian countries and regions, including South Korea, China, Northern Vietnam, and far-eastern Russia. China has the largest population of infected people.

In the acute phase, heavier infections can cause fever, chills, epigastric pain, tender hepatomegaly, mild jaundice, and eosinophilia occur.

Get PDF with Technological Advancement @ https://www.marketresearchfuture.com/sample_request/4686

Chronic cholangitis in heavy infections, which may progress to atrophy of liver parenchyma, portal fibrosis, and cirrhosis. Increasing prevalence of clonorchiasis, changing lifestyle, poor diet, and increasing geriatric population have driven the growth of the market.

Global Clonorchiasis Market -Key Players

Pfizer (U.S)

Bayer AG (Germany)

Provet (Switzerland)

Virbac (India)

Cipla (India)

Novartis AG (Switzerland)

CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India)

Merck & Co., Inc. (U.S.)

F. Hoffmann-La Roche Ltd. (Switzerland)

Abbott (U.S.)

The Global Clonorchiasis Market is expected to grow at a CAGR of 5.4% during the forecast period.

Global Clonorchiasis Market -Segmentation

The Global Clonorchiasis Market is segmented on the basis of parasites, therapy, and end users.On the basis of the parasites, the market is segmented into Clonorchis sinensis, Opisthorchis viverrini, Opisthorchis felineus, and others.

For Detailed Reading Visit @ https://www.marketresearchfuture.com/reports/clonorchiasis-market-4686

On the basis of the therapy, the market is segmented into diagnosis and treatment. The diagnosis is further segmented into microscopic examination, X-ray, serologic tests, and others.

The treatment is sub-segmented into praziquantel, cesol, cisticid, biltricide, and others.On the basis of end users, the market is segmented into hospital, clinics, and others.

Global Clonorchiasis Market -Regional Analysis

The Americas dominate the global clonorchiasis market owing to a large geriatric population, strong government support for research & development, and high healthcare spending. According to the Centers for Disease Control and Prevention in 2014, over 14.8 million of the U.S. population had GI diseases.

Europe is the second leading market across the globe, which is followed by Asia Pacific. Asia Pacific is the fastest growing market for Clonorchiasis. Asia Pacific clonorchiasis market is majorly driven by India, China, and South Korea owing to a huge patient pool, and continuously developing healthcare sector have fuelled the growth of the market.

China has the largest population of infected people with Clonorchis sinensis. In 2013, over 13 million people were infected in China.

The Middle East and Africa contribute the least in the growth of the global clonorchiasis market. However, the Middle East is dominating the market of this region. The UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East market.

Feel Free to Ask Any Query @ https://www.marketresearchfuture.com/enquiry/4686

Global Clonorchiasis -Some Points from TOC

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

..Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.